The page is the record's research on the issuer — no analyst, no rating, no view. # CHUGAI PHARMACEUTICAL CO.,LTD. (Prime Market: 4519) — research page As of 2026-11-06 · jp-cm-kg · record version 1 ## Identity and listing The issuer is CHUGAI PHARMACEUTICAL CO.,LTD., listed on the Prime Market under ticker 4519, ISIN JP3519400000, LEI 529900T9LAII161DCN95. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted. ## The disclosure read The record holds 6 filings in the window 2025-11-06 to 2026-11-06, on 3 filing days, comprising 1 ad hoc, 3 regulatory filings and 2 results. The median gap between filing days is 62.0 days. The latest filing is dated 2026-07-27 and is a regulatory filing, 102 days before the record date of 2026-11-06. The Prime Market median is 10 filings, a median cadence gap of 29.0 days and a median latency of 70.0 days across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a median cadence gap of 49.5 days and a median latency of 85.0 days across 80 issuers. ## Auditor The auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. Auditor changes are not on the record. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as this market's register has no lifecycle type map yet. The halt flag shows listed, not halted. ## Orderability For the client category Qualified Institutional Investors, the outcome is not determinable, with no signal code. The reason given is that the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's own investor-relations page names 18 research houses: BofA Securities Japan Co., Ltd.; Citigroup Global Markets Japan Inc.; CLSA; Daiwa Securities Co. Ltd.; Goldman Sachs Japan Co., Ltd.; Jefferies (Japan) Limited; J.P. Morgan Securities plc; Macquarie Capital; Mizuho Securities Co., Ltd.; Morgan Stanley MUFG Securities Co., Ltd.; Morningstar; Nomura Securities Co., Ltd.; Sanford C. Bernstein Japan KK; SBI SECURITIES Co.,Ltd.; SMBC Nikko Securities Inc.; UBS Securities Japan Co., Ltd; Morgan Stanley; and MUFG Securities Co., Ltd. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record. ## Sources 10 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4519 (the disclosure lines) - https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag) - https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XTBJ (the auditor) - https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html (coverage) - https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4519 (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-PRIME/4519 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp